Chun Cheng

454 total citations
12 papers, 359 citations indexed

About

Chun Cheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chun Cheng has authored 12 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Chun Cheng's work include RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Cells and Metastasis (2 papers). Chun Cheng is often cited by papers focused on RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Cells and Metastasis (2 papers). Chun Cheng collaborates with scholars based in China, Canada and United States. Chun Cheng's co-authors include Yi Sang, Jianjun Tang, Xiaofeng Tang, Lei Zeng, Xiaobin Lv, Kaishun Hu, Siwei Li, Wei‐Ping Min, Liping Li and Guofu Huang and has published in prestigious journals such as Oncogene, Scientific Reports and Journal of Cellular Biochemistry.

In The Last Decade

Chun Cheng

12 papers receiving 356 citations

Peers

Chun Cheng

MB

CR

ONCOL

PRM

CB

Weizhi Xu China

Yannasittha Jiramongkol United Kingdom

Meng Wu China

Daniela Danková Denmark

Shengze Deng China

Li-Yun Gong China

Emily Montal United States

Xiaobin Bai China

Kehan Ren China

Qiuting Feng China

Weizhi Xu China

Chun Cheng

299 ×1.1

MB

104 ×0.6

CR

65 ×1.4

ONCOL

40 ×1.0

PRM

54 ×1.5

CB

Citations per year, relative to Chun Cheng Chun Cheng (= 1×) peers Weizhi Xu

Countries citing papers authored by Chun Cheng

Since Specialization

Citations

This map shows the geographic impact of Chun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun Cheng more than expected).

Fields of papers citing papers by Chun Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun Cheng. The network helps show where Chun Cheng may publish in the future.

Co-authorship network of co-authors of Chun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Chun Cheng. A scholar is included among the top collaborators of Chun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun Cheng. Chun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Zhu, Mengqi, Jianping Zhang, Saiyan Bian, et al.. (2022). Circadian gene CSNK1D promoted the progression of hepatocellular carcinoma by activating Wnt/β-catenin pathway via stabilizing Dishevelled Segment Polarity Protein 3. Biological Procedures Online. 24(1). 21–21. 9 indexed citations

2.

Cheng, Chun, Siwei Li, Jun Yang, et al.. (2021). CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing β-catenin. Oncogene. 40(16). 2842–2857. 33 indexed citations

3.

Cheng, Chun, Jun Yang, Siwei Li, et al.. (2021). HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target. Cell Death and Disease. 12(2). 137–137. 39 indexed citations

4.

Cheng, Chun, Minxin Shi, Haimin Lu, et al.. (2020). miR-125b prevent the progression of esophageal squamous cell carcinoma through the p38-MAPK signaling pathway. Journal of Gastrointestinal Oncology. 11(6). 1113–1122. 5 indexed citations

5.

Huang, Zhaohao, Chun Cheng, Kaddie Kwok Chen, et al.. (2018). NRP1 promotes cell migration and invasion and serves as a therapeutic target in nasopharyngeal carcinoma.. PubMed. 11(5). 2460–2469. 11 indexed citations

6.

Sang, Yi, Chun Cheng, Yi‐Xin Zeng, & Tiebang Kang. (2018). Snail promotes metastasis of nasopharyngeal carcinoma partly by down‐regulating TEL2. Cancer Communications. 38(1). 58–58. 19 indexed citations

7.

Sang, Yi, Jianjun Tang, Siwei Li, et al.. (2016). LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16INK4A expression. Scientific Reports. 6(1). 22366–22366. 57 indexed citations

8.

Tang, Xiaofeng, Jianjun Tang, Xia Liu, et al.. (2016). Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis. Oncology Reports. 35(5). 2963–2969. 46 indexed citations

9.

Sang, Yi, Chun Cheng, Xiaofeng Tang, Meifang Zhang, & Xiaobin Lv. (2015). Hypermethylation of TET1 Promoter Is a New Diagnosic Marker for Breast Cancer Metastasis. Asian Pacific Journal of Cancer Prevention. 16(3). 1197–1200. 16 indexed citations

10.

Lv, Xiaobin, Lijuan Liu, Chun Cheng, et al.. (2015). SUN2 exerts tumor suppressor functions by suppressing the Warburg effect in lung cancer. Scientific Reports. 5(1). 17940–17940. 72 indexed citations

11.

Li, Li, Qian Liu, Xin Xiong, et al.. (2013). Neuroglobin Promotes Neurite Outgrowth via Differential Binding to PTEN and Akt. Molecular Neurobiology. 49(1). 149–162. 38 indexed citations

12.

Yang, Xiaojing, Lei Cheng, Mei Li, et al.. (2013). High Expression of SGTA in Esophageal Squamous Cell Carcinoma Correlates With Proliferation and Poor Prognosis. Journal of Cellular Biochemistry. 115(1). 141–150. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact